Login / Signup

Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection.

Jianmin J ZuoAlexander C DowellHayden PearceKriti VermaHeather M LongJusnara BegumFelicity AianoZahin Amin-ChowdhuryKatja HoschlerTim BrooksStephen TaylorJacqueline HewsonBassam HallisLorrain StapleyRay BorrowEzra LinleyShazaad AhmadBen ParkerAlex Robert HorsleyGayatri AmirthalingamKevin BrownMary E RamsayShamez LadhaniPaul A H Moss
Published in: Nature immunology (2021)
The immune response to SARS-CoV-2 is critical in controlling disease, but there is concern that waning immunity may predispose to reinfection. We analyzed the magnitude and phenotype of the SARS-CoV-2-specific T cell response in 100 donors at 6 months following infection. T cell responses were present by ELISPOT and/or intracellular cytokine staining analysis in all donors and characterized by predominant CD4+ T cell responses with strong interleukin (IL)-2 cytokine expression. Median T cell responses were 50% higher in donors who had experienced a symptomatic infection, indicating that the severity of primary infection establishes a 'set point' for cellular immunity. T cell responses to spike and nucleoprotein/membrane proteins were correlated with peak antibody levels. Furthermore, higher levels of nucleoprotein-specific T cells were associated with preservation of nucleoprotein-specific antibody level although no such correlation was observed in relation to spike-specific responses. In conclusion, our data are reassuring that functional SARS-CoV-2-specific T cell responses are retained at 6 months following infection.
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • kidney transplantation
  • long non coding rna
  • reactive oxygen species
  • big data
  • flow cytometry